29/03/2026
The bottom line - quality chocolate can increase life expectancy coffee & tea reduce dementia risk
Across human history, our relationship with plant alkaloids has been intimate, ambivalent and profoundly influential. These often bitter, physiologically potent nitrogen-containing compounds have shaped medicine, ritual, warfare, agriculture and addiction alike. From caffeine in tea and coffee, to morphine from o***m poppy, quinine from cinchona, ni****ne from to***co, and atropine from belladonna, alkaloids have altered mood, perception, pain, immunity and cardiovascular tone with a potency and specificity that conceptually foreshadowed modern pharmacology.
Most alkaloids are biologically potent precisely because they are toxic in higher doses. Many were designed by the plant as defence chemicals able to interfere with neural transmission, ion channels or enzymatic pathways. Their therapeutic window is often narrow. The major exception in everyday human use is the xanthine alkaloids, caffeine in tea and coffee, and theobromine (with small amounts of caffeine) in cocoa, which are comparatively mild central nervous system stimulants with a wide safety margin at customary dietary intakes. One might even say that human cultures appear to have instinctively selected and preserved xanthine-alkaloid-containing plants as daily companions: an implicit, cross-civilisational recognition that their gentle properties confer functional benefits without crossing into the toxicity that characterises most other alkaloids.
Now two recent studies add weight to the assertion that there might be substantial health benefits from the regular consumption of xanthine alkaloids. A 2025 population-based study examined whether circulating theobromine was associated with epigenetic markers of biological ageing in two European cohorts. In the discovery TwinsUK sample (n = 509), each unit increase in metabolomically derived circulating theobromine was associated with 1.6 fewer years of GrimAge acceleration (p = 3.99 × 10⁻⁶) and significantly longer DNA methylation-based telomere length (DNAmTL , p = 0.0029). These findings were replicated in the larger KORA cohort (n = 1,160), where theobromine was associated with approximately 1.1 fewer biological years of GrimAge acceleration (p = 7.2 × 10⁻⁸) and longer DNAmTL (p = 0.007). Note the extraordinarily low p values, indicating very high statistical significance.
Importantly, theobromine was not measured using a targeted quantitative chemical assay, nor was cocoa intake directly assessed; instead, its exposure was identified through blood metabolomic profiling. So, the association reflects circulating levels at a single time point using an objective exposure marker, but one shaped by recent intake and individual metabolism rather than a precise measure of long-term cocoa consumption. However, the authors regarded their metabolomic profiling of circulating theobromine as a more biologically integrated and objective measure of systemic exposure, arguably more reflective of intake and metabolism than self-reported dietary data. Sensitivity analyses including covariates of other cocoa and coffee metabolites suggested that the observed effects were specific to theobromine.
Biologically, the results for theobromine are plausible from its known properties and consistent with contemporary ageing mechanisms. While observational and not proof of causality, the magnitude (roughly 1 to 1.5 years difference in epigenetic age acceleration across exposure variation) is statistically robust yet biologically modest. It positions theobromine as just one among many phytonutrients that, when combined (like in my microcirculation diet), might substantially decelerate biological ageing.
The second study was a new prospective cohort study. Researchers sought to clarify the relationships between tea and coffee consumption and cognitive decline using repeated, detailed dietary assessments across two independent cohorts. Participants in the National Health Service (NHS) (n = 86,606 women; mean age at baseline, 46.2 years) and the Health Professionals Follow-up Study (n = 45,215 men; mean age at baseline, 53.8 years) completed repeated food frequency questionnaires every 2 to 4 years to assess caffeinated and decaffeinated coffee and tea intake.
Over a follow-up period of up to 43 years, 11,033 participants developed dementia. Moderate caffeinated coffee intake of about 2 to 3 cups/day was associated with an 18% lower risk for incident dementia compared with no coffee (hazard ratio [HR], 0.82; 95% CI, 0.76 to 0.89). Tea consumption showed a similar pattern, with participants who reported moderate tea intake (1 to 2 cups/day) showing a 14% lower risk for dementia than those who drank no tea (HR, 0.86; 95% CI, 0.83 to 0.90).
In contrast, decaffeinated coffee intake was not associated with a reduced risk for dementia.
“The decaf findings suggest that caffeine may be an important contributor because caffeinated coffee and tea showed more consistent associations than decaffeinated coffee,” lead author Zhang said.
Both green tea and cocoa (ideally as 85 to 90% dark chocolate) form core pillars of my microcirculation diet. The evidence supporting their broad vascular and cardiometabolic benefits continues to strengthen, and is now further enriched by the emerging data suggesting that the resultant coincidental intake of xanthine alkaloids may also meaningfully contribute to healthy ageing biology.
For more information see:
https://pubmed.ncbi.nlm.nih.gov/41397115/
https://www.medscape.com/viewarticle/coffee-and-tea-may-protect-against-dementia-hold-decaf-2026a100046l?ecd=mkm_ret_260220_mscpmrk-OUS_ICYMI_etid8114469&uac=48709HJ&impID=8114469
